Diclofenac associated with cardiovascular health risk

A 20-year population-based study has found the use of diclofenac for pain relief is linked to an increased risk of major adverse cardiovascular events...

Just what the pharmacist ordered

Pharmacist prescribing is ‘imminent’, says PSA National President Dr Shane Jackson. So what could that mean for you and your patients? Pharmacists will have...

HMR in remote Indigenous communities

Providing Home Medicines Reviews (HMR) in remote Indigenous communities has been challenging yet rewarding. I feel privileged to have been able to experience the...

Complementary medicines: Heart failure

Heart failure (HF), also referred to as congestive cardiac failure, is present in 1–2% of the Australian population.1 It is the end result of...

Australia excels on the global pharmacy stage

Australian pharmacy professionals have received top honours at the 78th FIP World Congress of Pharmacy and Pharmaceutical Sciences in Glasgow, while PSA has been...

Choosing wisely: sedatives

In the third of a six-part series, we expand on the PSA Choosing Wisely recommendations, taking a closer look at the use of sedatives....